Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert R Henry

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
Diabetes Care|June 16, 2018
Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary SyndromeIlse C Schrieks, Anna Nozza, Barbara E Stähli, et al.
Age (Dordrecht, Netherlands)|September 3, 2016
Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose toleranceSara E Espinoza, Chen-Pin Wang, Devjit Tripathy, et al.
Diabetes Care|June 21, 2014
Basal insulin peglispro demonstrates preferential hepatic versus peripheral action relative to insulin glargine in healthy subjectsRobert R Henry, Sunder Mudaliar, Theodore P Ciaraldi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2013
Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrierAjit S Divakaruni, Sandra E Wiley, George W Rogers, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 24, 2012
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factorsAramesh Saremi, Dawn C Schwenke, Thomas A Buchanan, et al.
The New England Journal of Medicine|March 25, 2011
Pioglitazone for diabetes prevention in impaired glucose toleranceRalph A DeFronzo, Devjit Tripathy, Dawn C Schwenke, et al.
Diabetes Care|August 6, 2014
Status of Diabetes Care: "It just doesn't get any better . . . or does it?"William T Cefalu, Andrew J M Boulton, William V Tamborlane, et al.
JCI Insight|November 23, 2021
p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytesVitor F Martins, Samuel A LaBarge, Alexandra Stanley, et al.
The Journal of Clinical Endocrinology and Metabolism|January 21, 2015
A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW studyDevjit Tripathy, Jeff E Cobb, Walter Gall, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 6, 2016
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARYAlan J Garber, Martin J Abrahamson, Joshua I Barzilay, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Diabetes Care|June 16, 2018
Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary SyndromeIlse C Schrieks, Anna Nozza, Barbara E Stähli, et al.
Age (Dordrecht, Netherlands)|September 3, 2016
Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose toleranceSara E Espinoza, Chen-Pin Wang, Devjit Tripathy, et al.
Diabetes Care|June 21, 2014
Basal insulin peglispro demonstrates preferential hepatic versus peripheral action relative to insulin glargine in healthy subjectsRobert R Henry, Sunder Mudaliar, Theodore P Ciaraldi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2013
Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrierAjit S Divakaruni, Sandra E Wiley, George W Rogers, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 24, 2012
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factorsAramesh Saremi, Dawn C Schwenke, Thomas A Buchanan, et al.
The New England Journal of Medicine|March 25, 2011
Pioglitazone for diabetes prevention in impaired glucose toleranceRalph A DeFronzo, Devjit Tripathy, Dawn C Schwenke, et al.
Diabetes Care|August 6, 2014
Status of Diabetes Care: "It just doesn't get any better . . . or does it?"William T Cefalu, Andrew J M Boulton, William V Tamborlane, et al.
JCI Insight|November 23, 2021
p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytesVitor F Martins, Samuel A LaBarge, Alexandra Stanley, et al.
The Journal of Clinical Endocrinology and Metabolism|January 21, 2015
A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW studyDevjit Tripathy, Jeff E Cobb, Walter Gall, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 6, 2016
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARYAlan J Garber, Martin J Abrahamson, Joshua I Barzilay, et al.
Pageof 16